Innovative Care for XLH Patients Begins
The NHS has taken a significant step forward in the treatment of X-linked hypophosphataemia (XLH), a rare genetic condition that causes rickets and a host of debilitating bone and dental problems. Adults with XLH can now access burosumab, a groundbreaking therapy that promises to transform lives by targeting the root cause of this challenging … [Read more…]
